共 191 条
[1]
Camps C(2007)Gene expression and polymorphisms of DNA repair enzymes: cancer susceptibility and response to chemotherapy Clin Lung Cancer 8 369-375
[2]
Sirera R(2008)Oxaliplatin doublets in non-small cell lung cancer: a literature review Lung Cancer 60 325-331
[3]
Iranzo V(2010)First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic review J Thorac Oncol 5 260-274
[4]
Taron M(2004)XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy J Clin Oncol 22 2594-2601
[5]
Rosell R(2004)Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer Ann Oncol 15 1194-1203
[6]
Cortinovis D(2010)Multiple roles of the ERCC1-XPF endonuclease in DNA repair and resistance to anticancer drugs Anticancer Res 30 3223-3232
[7]
Bidoli P(2009)The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair Science 326 1698-1701
[8]
Zilembo N(2007)Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer Ann Oncol 18 504-509
[9]
Fusi A(2007)No association of ERCC1 C8092A and T19007C polymorphisms to cancer risk: a meta-analysis Eur J Hum Genet 15 967-973
[10]
Bajetta E(2007)Genetic variation in the DNA repair genes is predictive of outcome in lung cancer Hum Mol Genet 16 2333-2340